LEGN vs. ADVM

Last updated Apr 1, 2026

Compare and contrast key facts about Legend Biotech Corporation (LEGN) and Adverum Biotechnologies, Inc. (ADVM).

Performance

LEGN vs. ADVM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Legend Biotech Corporation (LEGN) and Adverum Biotechnologies, Inc. (ADVM). The values are adjusted to include any dividend payments, if applicable.

LEGN vs. ADVM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
LEGN Legend Biotech Corporation	-16.79%	-33.19%	-45.92%	20.53%	7.10%	65.52%	-23.89%
ADVM Adverum Biotechnologies, Inc.	0.00%	-6.64%	-37.96%	29.91%	-67.07%	-83.76%	-52.17%

Fundamentals

Market Cap LEGN : $1.67B ADVM : $102.40M
EPS LEGN : -$3.22 ADVM : -$9.19
Total Revenue (TTM) LEGN : $1.03B ADVM : $0.00
Gross Profit (TTM) LEGN : $621.40M ADVM : -$465.00K
EBITDA (TTM) LEGN : -$243.52M ADVM : -$205.45M

Returns By Period

LEGN

• 1D: 4.51%
• 1M: -4.79%
• YTD: -16.79%
• 6M: -44.53%
• 1Y: -46.68%
• 3Y*: -27.88%
• 5Y*: -8.72%
• 10Y*: —

ADVM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: -3.75%
• 1Y: -0.23%
• 3Y*: -15.30%
• 5Y*: -46.64%
• 10Y*: -21.95%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

LEGN vs. ADVM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LEGN

LEGN Risk / Return Rank: 9
LEGN Sharpe Ratio Rank: 5
LEGN Sortino Ratio Rank: 6
LEGN Omega Ratio Rank: 8
LEGN Calmar Ratio Rank: 14
LEGN Martin Ratio Rank: 13

ADVM

ADVM Risk / Return Rank: 43
ADVM Sharpe Ratio Rank: 41
ADVM Sortino Ratio Rank: 46
ADVM Omega Ratio Rank: 45
ADVM Calmar Ratio Rank: 41
ADVM Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LEGN vs. ADVM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Legend Biotech Corporation (LEGN) and Adverum Biotechnologies, Inc. (ADVM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LEGN	ADVM	Difference
Sharpe ratio Return per unit of total volatility	-0.97	-0.00	-0.97
Sortino ratio Return per unit of downside risk	-1.48	0.65	-2.13
Omega ratio Gain probability vs. loss probability	0.83	1.08	-0.25
Calmar ratio Return relative to maximum drawdown	-0.78	0.00	-0.78
Martin ratio Return relative to average drawdown	-1.38	0.00	-1.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LEGN vs. ADVM - Sharpe Ratio Comparison

The current LEGN Sharpe Ratio is -0.97, which is lower than the ADVM Sharpe Ratio of -0.00. The chart below compares the historical Sharpe Ratios of LEGN and ADVM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	LEGN	ADVM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.97	-0.00	-0.97
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.17	-0.58	+0.41
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.27	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.22	-0.32	+0.09

Correlation

The correlation between LEGN and ADVM is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

LEGN vs. ADVM - Dividend Comparison

Neither LEGN nor ADVM has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

LEGN vs. ADVM - Drawdown Comparison

The maximum LEGN drawdown since its inception was -78.24%, smaller than the maximum ADVM drawdown of -99.20%. Use the drawdown chart below to compare losses from any high point for LEGN and ADVM.

Drawdown Indicators

	LEGN	ADVM	Difference
Max Drawdown Largest peak-to-trough decline	-78.24%	-99.20%	+20.96%
Max Drawdown (1Y) Largest decline over 1 year	-62.43%	-51.88%	-10.55%
Max Drawdown (5Y) Largest decline over 5 years	-78.24%	-98.06%	+19.82%
Max Drawdown (10Y) Largest decline over 10 years	—	-99.20%	—
Current Drawdown Current decline from peak	-76.35%	-98.30%	+21.95%
Average Drawdown Average peak-to-trough decline	-30.26%	-69.22%	+38.96%
Ulcer Index Depth and duration of drawdowns from previous peaks	35.09%	37.57%	-2.48%

Volatility

LEGN vs. ADVM - Volatility Comparison

Legend Biotech Corporation (LEGN) has a higher volatility of 14.31% compared to Adverum Biotechnologies, Inc. (ADVM) at 0.00%. This indicates that LEGN's price experiences larger fluctuations and is considered to be riskier than ADVM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LEGN	ADVM	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.31%	0.00%	+14.31%
Volatility (6M) Calculated over the trailing 6-month period	34.00%	49.53%	-15.53%
Volatility (1Y) Calculated over the trailing 1-year period	48.21%	84.24%	-36.03%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	51.77%	82.34%	-30.57%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	51.80%	81.88%	-30.08%

Financials